Motilal Oswal - Hero Motocorp Limited (HEROMOTOCO) MOSL: HERO MOTOCORP (Neutral)-Key strategy to play around core strength, while growth in 125cc scooter and premium motorcycles

Report

Motilal Oswal

Jinesh Gandhi

EUR 120.00 For Business Accounts Only

MOSL: HERO MOTOCORP (Neutral)-Key strategy to play around core strength, while growth in 125cc scooter and premium motorcycles

Hero MotoCorp: Key strategy to play around core strength, while growth in 125cc scooter and premium motorcycles in sight

(HMCL IN, Mkt Cap USD7.8b, CMP INR2718, TP INR2912, 7% Upside, Neutral)

We met Mr. Niranjan Gupta (CFO), Mr Sanjay Bhan (Head – Sales) and Mr Malo Le Masson (Head – Global Product Planning) of Hero MotoCorp (HMCL) () to get an update on the (a) long-term growth potential of the domestic 2W industry, (b) product positioning in the 125cc Scooter and Premium motorcycle segments, (c) company’s strategy and preparedness for BS-VI regulations, and (d) the scale-up in the global business. Management is not only confident of providing right value proposition to customers under BS-VI, but is also certain of remaining the top choice for consumers in a growing competitive environment.

31/05/2019 1 EN

Underlying

Hero Motocorp Limited

Hero MotoCorp is engaged in the production and sale of motorized two wheelers up to 350cc engine capacity for both domestic and international markets.

See profile

INE158A01026 National Stock Exchange of India India

Provider

Motilal Oswal

Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance.

Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.

See profile

Analysts

Jinesh Gandhi

Other Reports on these Companies

SmartInsider

Hero MotoCorp Ltd: 1 director

A director at Hero MotoCorp Ltd bought 43,100 shares at 2,309.203INR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names ...

Free Trial

April 5, 2022 April 5, 2022 1 EN

TheScreener

HERO MOTOCORP sees an upgrade to Slightly Positive due to a better fundamental star rating

The general evaluation of HERO MOTOCORP (IN), a company active in the Automobiles industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date January 18, 2022, the closing price was INR 2,692.85 and its potential was estimated at INR 2,831.26.

Free Trial

January 19, 2022 January 19, 2022 1 EN

Motilal Oswal

MOSL: HERO MOTOCORP (Buy)- In-line results; reasonable performance in a tough environment

HERO MOTOCORP: In-line results; reasonable performance in a tough environment (HMCL IN, Mkt Cap USD7.5b, CMP INR2772, TP INR3400, 23% Upside, Buy) Positive outlook with upcoming festive season Hero MotoCorp (HMCL)’s performance was driven by efficient cost management despite high cost inflation and op. deleverage. While cost inflation is being managed reasonably well, demand recovery is the missing link in the story. We cut our FY22E/FY23E EPS by 5%/1%, factoring in delayed volume recovery. We maintain our Buy rating, with TP of INR3,400 (~15x Mar’23 S/A EPS + INR154/share for Hero Fi...

EUR 120.00

August 14, 2021 August 14, 2021 12 EN

MOSL : HOME FIRST FINANCE COMPANY: Earnings in-line with sustained improvement in asset quality

HOME FIRST FINANCE COMPANY: Earnings in-line with sustained improvement in asset quality (HOMEFIRS IN, Mkt Cap USD0.9b, CMP INR802, TP INR1025, 28% Upside, Buy) HomeFirst’s 2QFY23 PAT grew 21% YoY/6% QoQ to INR543m (in-line). Credit costs grew 37% QoQ to INR50m (MOFSLe: INR31m). Underlying this, the NII grew 58% YoY to ~INR1b (in-line). ‘Other income’ grew 13% QoQ, driven primarily by higher treasury gains and investment income. Opex was 7% higher than estimated and grew 47% YoY and 14% QoQ, led by investments in new branches and resultant higher employee expenses. Disbursements grew 36%...

EUR 120.00

October 21, 2022 October 21, 2022 12 EN

Aliasgar Shakir

Aliasgar Shakir

MOSL : SHOPPERS STOP: Ticking the right boxes

. SHOPPERS STOP: Ticking the right boxes (SHOP IN, Mkt Cap USD1b, CMP INR780, TP INR805, 3% Upside, Neutral) Aided by price hikes, SHOP reported a healthy 19% revenue growth in 2QFY23 from pre-COVID levels (8% beat) on healthy (+10%) SSSG and sustained volumes. EBITDA grew 2.3x YoY (22% over pre-COVID levels), with a 540bp margin improvement. 1) A strong recovery in revenue, backed by an improved pricing; 2) expansion within the Beauty and Private Label segment; and 3) healthy annual 12/15 store additions for SHOP/Beauty are expected to drive business growth going forward. We expect a r...

EUR 120.00

October 21, 2022 October 21, 2022 13 EN

Tushar Manudhane

Tushar Manudhane

MOSL : ERIS LIFESCIENCES: Enhanced efforts toward product launch-related activities

ERIS LIFESCIENCES: Enhanced efforts toward product launch-related activities (ERIS IN, Mkt Cap USD1.2b, CMP INR708, TP INR860, 21% Upside, Buy) Eris Lifesciences (ERIS) delivered better than expected 2QFY23 performance, led by superior traction in new launches and improved operating leverage. ERIS is notonly sustaining the momentum in its recently launched products, but it is also preparing itself for an aggressive pace of new introductions. We reiterate our earnings estimate for FY23/FY24 and continue to value ERIS at 22x 12M forward earnings to arrive at a price target of INR860. We re...

EUR 120.00

October 21, 2022 October 21, 2022 11 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

MOSL: HERO MOTOCORP (Neutral)-Key strategy to play around core strength, while growth in 125cc scooter and premium motorcycles

Hero MotoCorp Ltd: 1 director

HERO MOTOCORP sees an upgrade to Slightly Positive due to a better fundamental star rating

MOSL: HERO MOTOCORP (Buy)- In-line results; reasonable performance in a tough environment

MOSL : HOME FIRST FINANCE COMPANY: Earnings in-line with sustained improvement in asset quality

MOSL : SHOPPERS STOP: Ticking the right boxes

MOSL : ERIS LIFESCIENCES: Enhanced efforts toward product launch-related activities

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe